In this regard, our evidence of higher serum concentrations of MR-proADM (but not KL-6 or IL-6) in patients experiencing AKI while in hospital further confirms the potential of this biomarker for prognostic estimation of organ failure. This evidence concerns the gene MUC1 and acute kidney injury.